Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test ...
Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...
Brazilian Society of Surgical Oncology: Realities and challenges of surgical oncologists in palliative care practice. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid unnecessary biopsies, officials have announced. About 15,000 patients a year are ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy ...
Lung cancer is one of the leading causes of death globally. 1 Tobacco smoking causes nearly 90% of lung cancers. The major histologic types of lung cancer include adenocarcinoma, squamous-cell ...
Scientists in Newcastle, where the test was developed, hailed it as a "revolution" A pioneering test is improving early diagnosis for people with hereditary cancer caused by a genetic condition. Just ...
Research shows a growing number of non- and never-smokers are getting diagnosed with lung cancer. Risks for never-smokers include poor air quality caused by pollution and wildfire smoke, occupational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results